CN Patent

CN115677659B — 一种阿雷替尼的制备方法

Assigned to Zaozhuang Runan Pharmaceutical New Material Co ltd · Expires 2024-03-22 · 2y expired

What this patent protects

本发明涉及一种阿雷替尼的制备方法，包括如下步骤： (1)中间体2与中间体3通过Ullmann反应，得到中间体4。本发明制备方法路线简短，成本低，反应条件温和，收率高，适合工业化生产。

USPTO Abstract

本发明涉及一种阿雷替尼的制备方法，包括如下步骤： (1)中间体2与中间体3通过Ullmann反应，得到中间体4。本发明制备方法路线简短，成本低，反应条件温和，收率高，适合工业化生产。

Drugs covered by this patent

Patent Metadata

Patent number
CN115677659B
Jurisdiction
CN
Classification
—
Expires
2024-03-22
Drug substance claim
No
Drug product claim
No
Assignee
Zaozhuang Runan Pharmaceutical New Material Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.